Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2021 Filed Jun 17, 2021 23:42 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 239 | $214.04 | $51,155.56 |
DisclosureSEC source: 0001713683-21-000115 · wf-form4_162397330136360.xml · nonDerivative · entry 2 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,157 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 23:42 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 3,905 | $213.46 | $833,566.77 |
DisclosureSEC source: 0001713683-21-000115 · wf-form4_162397330136360.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,157 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 19:41 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 4,678 | $213.46 | $998,572.43 |
DisclosureSEC source: 0001713683-21-000113 · wf-form4_162397322985056.xml · nonDerivative · entry 1 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,280 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 239 shares acquired under the Issuer's Fiscal Year 2018 Employee Stock Purchase Plan on June 15, 2021. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 23:42 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 8,113 | $213.46 | $1,731,812.34 |
DisclosureSEC source: 0001713683-21-000116 · wf-form4_162397333717772.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,318 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 239 shares acquired under the Issuer's Fiscal Year 2018 Employee Stock Purchase Plan on June 15, 2021. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 2,156 | $200.08 | $431,369.68 |
DisclosureSEC source: 0001713683-21-000105 · wf-form4_162336514726972.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,062 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 18:45 UTC |
CANESSA REMOChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,196 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000104 · wf-form4_162336512767860.xml · derivative · entry 3 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,196 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 18:45 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 51,196 | $200.01 | $10,239,604.45 |
DisclosureSEC source: 0001713683-21-000104 · wf-form4_162336512767860.xml · nonDerivative · entry 2 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,719 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 4, 2021, as amended April 6, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 18:45 UTC |
CANESSA REMOChief Financial Officer
|
Exercise / conversionCommon Stock | 51,196 | $5.82 | $297,960.72 |
DisclosureSEC source: 0001713683-21-000104 · wf-form4_162336512767860.xml · nonDerivative · entry 1 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · derivative · entry 16 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,002 | $204.86 | $205,272.43 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 9 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F9 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $204.65 to $205.52, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,500 | $204.26 | $306,384.00 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,194 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $203.64 to $204.60, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $202.98 | $142,089.01 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,694 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $202.60 to $203.36, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 800 | $201.77 | $161,414.00 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,394 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $201.34 to $202.28, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,100 | $200.87 | $220,961.95 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,194 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $200.29 to $201.20, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,000 | $199.67 | $199,674.00 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,294 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $199.15 to $200.03, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $198.58 | $139,006.98 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,294 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $197.96 to $198.92, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 198 | $195.32 | $38,672.51 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,994 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.25 to $195.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4. Read SEC document |
| June 10, 2021 Filed Jun 10, 2021 22:46 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000106 · wf-form4_162336517298698.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 18:38 UTC |
Rajic DaliPres Go-To-Mkt/ Chief Rev Ofcr
|
SaleCommon Stock | 12,943 | $195.78 | $2,534,027.13 |
DisclosureSEC source: 0001713683-21-000100 · wf-form4_162336468991236.xml · nonDerivative · entry 1 Rajic Dali · CIK 0001695005 · Pres Go-To-Mkt/ Chief Rev Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,213 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.70 to $196.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · derivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 202 | $193.22 | $39,030.88 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $193.21 to $193.44, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 394 | $192.54 | $75,862.18 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $192.21 to $192.83, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 502 | $190.42 | $95,590.79 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,359 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $189.90 to $190.89, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $188.85 | $18,885.00 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,861 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $186.64 | $18,664.00 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,961 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 702 | $184.83 | $129,751.08 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,061 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.17 to $185.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 01:47 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000098 · wf-form4_162311684999429.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · derivative · entry 6 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,196 Underlying: Common Stock · 10,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 700 | $192.89 | $135,023.00 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · nonDerivative · entry 5 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,719 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 4, 2021, as amended April 6, 2021. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 1,780 | $191.87 | $341,528.60 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · nonDerivative · entry 4 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,419 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 4, 2021, as amended April 6, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $191.61 to $192.405, inclusive. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 6,620 | $191.15 | $1,265,413.00 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · nonDerivative · entry 3 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,199 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 4, 2021, as amended April 6, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $190.56 to $191.54, inclusive. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 900 | $189.95 | $170,955.00 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · nonDerivative · entry 2 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,819 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 4, 2021, as amended April 6, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.49 to $190.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:19 UTC |
CANESSA REMOChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $5.82 | $58,200.00 |
DisclosureSEC source: 0001713683-21-000094 · wf-form4_162275151242152.xml · nonDerivative · entry 1 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · derivative · entry 15 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $195.63 | $58,689.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,192 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $195.59 to $195.66, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,200 | $194.67 | $233,606.04 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,492 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $194.43 to $195.33, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 3,400 | $193.85 | $659,104.96 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,692 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $193.28 to $194.27, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $192.90 | $173,610.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,092 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $192.26 to $193.21, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $190.71 | $76,282.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,992 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $190.61 to $190.88, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $190.00 | $76,001.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,392 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $189.51 to $190.28, inclusive. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $189.03 | $75,613.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,792 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.48 to $189.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000089 · wf-form4_162223417654335.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2021 Filed May 26, 2021 23:14 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000087 · wf-form4_162207083394777.xml · derivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,334 Underlying: Common Stock · 1,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| May 26, 2021 Filed May 26, 2021 23:14 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 1,000 | $195.00 | $195,000.00 |
DisclosureSEC source: 0001713683-21-000087 · wf-form4_162207083394777.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| May 26, 2021 Filed May 26, 2021 23:14 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 1,000 | $5.82 | $5,820.00 |
DisclosureSEC source: 0001713683-21-000087 · wf-form4_162207083394777.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:09 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000085 · wf-form4_162197693782028.xml · derivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,334 Underlying: Common Stock · 1,500 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:09 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 800 | $175.17 | $140,139.04 |
DisclosureSEC source: 0001713683-21-000085 · wf-form4_162197693782028.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $174.745 to $175.68, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:09 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 620 | $174.33 | $108,082.80 |
DisclosureSEC source: 0001713683-21-000085 · wf-form4_162197693782028.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,563 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $173.74 to $174.68, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:09 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 80 | $172.51 | $13,801.00 |
DisclosureSEC source: 0001713683-21-000085 · wf-form4_162197693782028.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,183 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.14 to $172.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:09 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 1,500 | $5.82 | $8,730.00 |
DisclosureSEC source: 0001713683-21-000085 · wf-form4_162197693782028.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.